Search research articles
Contact Us
Filters
Showing results (101-110 of 131) with videos related to
Page
of 14
Sort By:
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
May 23, 2018
Time dependent loss of trabecular bone in human tibial plateau fractures
Lucian B Solomon, David Kitchen, Paul H Anderson, et al.
Inflammopharmacology
|
October 16, 2013
Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management
Donald W Howie, Susan D Neale, David R Haynes, et al.
Anticancer Research
|
December 16, 2014
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs)
Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 10, 2017
Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D<sub>3</sub> on osteoblast differentiation
Dongqing Yang, Paul H Anderson, Asiri R Wijenayaka, et al.
Cancer Letters
|
December 3, 2014
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma
Vasilios Liapis, Agatha Labrinidis, Irene Zinonos, et al.
Molecular and Cellular Endocrinology
|
November 13, 2016
Peroxidase enzymes inhibit osteoclast differentiation and bone resorption
Vasilios Panagopoulos, Vasilios Liapis, Irene Zinonos, et al.
Calcified Tissue International
|
May 26, 2022
A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene
Jochen G Hofstaetter, Gerald J Atkins, Hajime Kato, et al.
Molecular and Cellular Endocrinology
|
June 27, 2015
1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion
Asiri R Wijenayaka, Dongqing Yang, Matthew Prideaux, et al.
Cancer Medicine
|
January 11, 2016
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models
Vasilios Liapis, Irene Zinonos, Agatha Labrinidis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma
Agatha Labrinidis, Peter Diamond, Sally Martin, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 131) with videos related to
Sort By:
Page
of 14
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
May 23, 2018
Time dependent loss of trabecular bone in human tibial plateau fractures
Lucian B Solomon, David Kitchen, Paul H Anderson, et al.
Inflammopharmacology
|
October 16, 2013
Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management
Donald W Howie, Susan D Neale, David R Haynes, et al.
Anticancer Research
|
December 16, 2014
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs)
Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 10, 2017
Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D<sub>3</sub> on osteoblast differentiation
Dongqing Yang, Paul H Anderson, Asiri R Wijenayaka, et al.
Cancer Letters
|
December 3, 2014
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma
Vasilios Liapis, Agatha Labrinidis, Irene Zinonos, et al.
Molecular and Cellular Endocrinology
|
November 13, 2016
Peroxidase enzymes inhibit osteoclast differentiation and bone resorption
Vasilios Panagopoulos, Vasilios Liapis, Irene Zinonos, et al.
Calcified Tissue International
|
May 26, 2022
A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene
Jochen G Hofstaetter, Gerald J Atkins, Hajime Kato, et al.
Molecular and Cellular Endocrinology
|
June 27, 2015
1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion
Asiri R Wijenayaka, Dongqing Yang, Matthew Prideaux, et al.
Cancer Medicine
|
January 11, 2016
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models
Vasilios Liapis, Irene Zinonos, Agatha Labrinidis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma
Agatha Labrinidis, Peter Diamond, Sally Martin, et al.
Page
of 14